{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:39:49Z","timestamp":1784975989575,"version":"3.55.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neurol.2022.11.010","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T19:38:27Z","timestamp":1677267507000},"page":"548-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Retinal vessels as a window on amyotrophic lateral sclerosis pathophysiology: A systematic review"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6674-3884","authenticated-orcid":false,"given":"A.","family":"Vautier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Codron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-3046","authenticated-orcid":false,"given":"P.","family":"Gohier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cassereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2022.11.010_bib0645","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0650","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chi\u00f2","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurol.2022.11.010_bib0655","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.neurol.2022.11.010_bib0660","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0665","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.neurol.2022.11.010_bib0670","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-510X(00)00422-6","article-title":"Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?","volume":"180","author":"Julien","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0675","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0680","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neulet.2016.04.065","article-title":"Oxidative stress and mitochondrial damage in the pathogenesis of ALS: new perspectives","volume":"636","author":"Bozzo","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2022.11.010_bib0685","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/187152710791292576","article-title":"Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target","volume":"9","author":"Bogaert","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neurol.2022.11.010_bib0690","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-018-1350-y","article-title":"Age-related deregulation of TDP-43 after stroke enhances NF-\u03baB-mediated inflammation and neuronal damage","volume":"15","author":"Thammisetty","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2022.11.010_bib0695","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4155\/cli.11.172","article-title":"Potential utility of biomarkers in the diagnosis and treatment of amyotrophic lateral sclerosis","volume":"2","author":"Cheah","year":"2012","journal-title":"Clin Invest"},{"key":"10.1016\/j.neurol.2022.11.010_bib0700","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1469-7580.2005.00395.x","article-title":"Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures","volume":"206","author":"Patton","year":"2005","journal-title":"J Anat"},{"key":"10.1016\/j.neurol.2022.11.010_bib0705","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjophthalmol-2017-310476","article-title":"Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia","volume":"102","author":"Bulut","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8538573","article-title":"Ocular manifestations of Alzheimer's and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer's disease","volume":"2018","author":"Colligris","year":"2018","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0715","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3390\/jcm9061706","article-title":"Optical coherence tomography angiography in neurodegenerative disorders","volume":"9","author":"Pellegrini","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.neurol.2022.11.010_bib0720","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neurol.2022.11.010_bib0725","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Syst Rev"},{"key":"10.1016\/j.neurol.2022.11.010_bib0730","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp-2015-311157","article-title":"Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis","volume":"87","author":"Turner","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.010_bib0735","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s00415-020-09799-z","article-title":"Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group","volume":"267","author":"Diekmann","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0740","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainres.2013.08.007","article-title":"Chronic cerebral ischemia induces redistribution and abnormal phosphorylation of transactivation-responsive DNA-binding protein-43 in mice","volume":"1533","author":"Shindo","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2022.11.010_bib0745","first-page":"1023","article-title":"Phosphorylated TDP-43 localizes to chronic cerebral infarctions in human brains","volume":"35","author":"Umahara","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0750","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","article-title":"Inflammation and neurovascular changes in amyotrophic lateral sclerosis","volume":"53","author":"Evans","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0755","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40478-021-01241-3","article-title":"The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS","volume":"9","author":"Kovacs","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurol.2022.11.010_bib0760","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0765","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jnr.22594","article-title":"Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"89","author":"Miyazaki","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurol.2022.11.010_bib0770","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.copbio.2021.10.021","article-title":"Neurovascular signals in amyotrophic lateral sclerosis","volume":"74","author":"Sorrentino","year":"2022","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0775","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.040238","article-title":"Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model","volume":"12","author":"Crivello","year":"2019","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.neurol.2022.11.010_bib0780","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1107\/S1600577520006785","article-title":"X-ray phase contrast tomography for the investigation of amyotrophic lateral sclerosis","volume":"27","author":"Begani Provinciali","year":"2020","journal-title":"J Synchrotron Rad"},{"key":"10.1016\/j.neurol.2022.11.010_bib0785","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1038\/s41598-019-41747-4","article-title":"Human bone marrow endothelial progenitor cell transplantation into symptomatic ALS mice delays disease progression and increases motor neuron survival by repairing blood-spinal cord barrier","volume":"9","author":"Garbuzova-Davis","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2022.11.010_bib0790","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-015-1520-2","article-title":"Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration","volume":"131","author":"Lewandowski","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0795","first-page":"81","article-title":"Postulated vasoactive neuropeptide immunopathology affecting the blood-brain\/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: a role for phosphodiesterase inhibitors in treatment?","volume":"5","author":"Staines","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neurol.2022.11.010_bib0800","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2022.11.010_bib0805","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jnen\/nlaa162","article-title":"TDP-43 vasculopathy in the spinal cord in sporadic amyotrophic lateral sclerosis (sALS) and frontal cortex in sALS\/FTLD-TDP","volume":"80","author":"Ferrer","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0810","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1073\/pnas.1218311110","article-title":"Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth","volume":"110","author":"Schmid","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2022.11.010_bib0815","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood\u2013spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0820","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","article-title":"Amyotrophic lateral sclerosis: a neurovascular disease","volume":"1398","author":"Garbuzova-Davis","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2022.11.010_bib0825","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/revneuro-2014-0049","article-title":"Microcirculation of the brain: morphological assessment in degenerative diseases and restoration processes","volume":"26","author":"Kolinko","year":"2015","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0830","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-030-16908-4_6","article-title":"The Role of pericytes in amyotrophic lateral sclerosis","volume":"1147","author":"Coatti","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0835","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00401-018-1893-0","article-title":"Targeting pericytes for therapeutic approaches to neurological disorders","volume":"136","author":"Cheng","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0840","article-title":"Altered perivascular fibroblast activity precedes ALS disease onset","volume":"27","author":"Manberg","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2022.11.010_bib0845","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/21678421.2015.1011663","article-title":"Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis","volume":"16","author":"Yamadera","year":"2015","journal-title":"Amyotroph Lateral Scher Frontotemp Degenerat"},{"key":"10.1016\/j.neurol.2022.11.010_bib0850","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/nan.12332","article-title":"Non-motor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy","volume":"43","author":"Nolano","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0855","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12015-017-9752-2","article-title":"Pericytes extend survival of ALS SOD1 mice and induce the expression of antioxidant enzymes in the murine model and in IPSCs derived neuronal cells from an ALS patient","volume":"13","author":"Coatti","year":"2017","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.neurol.2022.11.010_bib0860","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nn.2947","article-title":"Cerebrovascular disorders: molecular insights and therapeutic opportunities","volume":"14","author":"Storkebaum","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0865","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fneur.2019.00889","article-title":"Small vessels are a big problem in neurodegeneration and neuroprotection","volume":"10","author":"Erdener \u015eE","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0870","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/01.ASN.0000024436.00520.D8","article-title":"VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures","volume":"13","author":"Kim","year":"2002","journal-title":"JASN"},{"key":"10.1016\/j.neurol.2022.11.010_bib0875","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000088637","article-title":"Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential","volume":"14","author":"Zachary","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.neurol.2022.11.010_bib0880","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2990.2004.00600.x","article-title":"Vascular endothelial growth factor and the nervous system","volume":"30","author":"Brockington","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0885","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and Therapeutic potential of VEGF in the nervous system","volume":"89","author":"De Almodovar","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neurol.2022.11.010_bib0890","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","article-title":"VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection","volume":"26","author":"Storkebaum","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.neurol.2022.11.010_bib0895","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbadis.2006.04.005","article-title":"VEGF at the neurovascular interface: therapeutic implications for motor neuron disease","volume":"1762","author":"Lambrechts","year":"2006","journal-title":"Biochim Biophys Acta (BBA)\u00a0\u2013\u00a0Mol Basis Dis"},{"key":"10.1016\/j.neurol.2022.11.010_bib0900","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1523\/JNEUROSCI.0434-06.2006","article-title":"Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1\/2 and Akt pathways","volume":"26","author":"Kilic","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0905","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fnmol.2018.00241","article-title":"Vascular endothelial growth factor (VEGF) prevents the downregulation of the cholinergic phenotype in axotomized motoneurons of the adult rat","volume":"11","author":"Acosta","year":"2018","journal-title":"Front Molec Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0910","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2022.11.010_bib0915","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0006-8993(03)03374-2","article-title":"Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene","volume":"989","author":"Murakami","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2022.11.010_bib0920","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1523\/JNEUROSCI.1092-08.2008","article-title":"Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration","volume":"28","author":"Poesen","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0925","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2004.12.031","article-title":"Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia","volume":"132","author":"Shiote","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2022.11.010_bib0930","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00429-020-02057-y","article-title":"Sources and lesion-induced changes of VEGF expression in brainstem motoneurons","volume":"225","author":"Silva-Hucha","year":"2020","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neurol.2022.11.010_bib0935","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jnen.0000196134.51217.74","article-title":"Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis","volume":"65","author":"Brockington","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0940","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1212\/01.WNL.0000129913.44351.A3","article-title":"Low levels of the vascular endothelial growth factor in CSF from early ALS patients","volume":"62","author":"Devos","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.010_bib0945","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clineuro.2003.12.007","article-title":"Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis","volume":"106","author":"I\u0142\u017cecka","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurol.2022.11.010_bib0950","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nmd.2006.10.004","article-title":"High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia","volume":"17","author":"Just","year":"2007","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.neurol.2022.11.010_bib0955","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-0040-1714314","article-title":"Association of plasma biomarkers for angiogenesis and proteinopathy in Indian amyotrophic lateral sclerosis patients","volume":"11","author":"Modgil","year":"2020","journal-title":"J Neurosci Rural Pract"},{"key":"10.1016\/j.neurol.2022.11.010_bib0960","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jns.2009.06.021","article-title":"Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis","volume":"285","author":"Suzuki","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0965","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nn1360","article-title":"Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS","volume":"8","author":"Storkebaum","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib0970","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.20223","article-title":"Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS","volume":"56","author":"Zheng","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib0975","doi-asserted-by":"crossref","first-page":"fcaa160","DOI":"10.1093\/braincomms\/fcaa160","article-title":"Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study","volume":"2","author":"Van Damme","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2022.11.010_bib0980","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1745-7270.2008.00442.x","article-title":"Mechanisms of action of angiogenin","volume":"40","author":"Gao","year":"2008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.neurol.2022.11.010_bib0985","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1212\/01.WNL.0000144344.39103.F6","article-title":"A novel candidate region for ALS on chromosome 14q11.2","volume":"63","author":"Greenway","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.010_bib0990","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","article-title":"ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis","volume":"38","author":"Greenway","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2022.11.010_bib0995","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.21221","article-title":"Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis","volume":"62","author":"Wu","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1000","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2007.03.009","article-title":"Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population","volume":"258","author":"Corrado","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1005","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/s41598-020-60431-6","article-title":"Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration","volume":"10","author":"Aluri","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2022.11.010_bib1010","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1021\/bi701333h","article-title":"Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis","volume":"46","author":"Crabtree","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurol.2022.11.010_bib1015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/hmg\/ddm095","article-title":"A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis","volume":"16","author":"Subramanian","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2022.11.010_bib1020","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/01.wnl.0000244466.46020.47","article-title":"Elevated serum angiogenin levels in ALS","volume":"67","author":"Cronin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.010_bib1025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2336","article-title":"Neurovascular signalling defects in neurodegeneration","volume":"9","author":"Zacchigna","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1030","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419871420","article-title":"Erythropoietin as a neuroprotective molecule: an overview of its therapeutic potential in neurodegenerative diseases","volume":"11","author":"Rey","year":"2019","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neurol.2022.11.010_bib1035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/cn500363g","article-title":"The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives","volume":"6","author":"Kaur","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1040","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1167\/iovs.09-5030","article-title":"Human extraocular muscles in ALS","volume":"51","author":"Ahmadi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1045","doi-asserted-by":"crossref","first-page":"e109833","DOI":"10.1371\/journal.pone.0109833","article-title":"Analysis of neurotrophic factors in limb and extraocular muscles of mouse model of amyotrophic lateral sclerosis","volume":"9","author":"Harandi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2022.11.010_bib1050","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1167\/iovs.17-22098","article-title":"Impact of amyotrophic lateral sclerosis on slow tonic myofiber composition in human extraocular muscles","volume":"58","author":"Tjust","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1055","first-page":"1547","article-title":"Unaffected motor endplate occupancy in eye muscles of ALS G93A mouse model","volume":"4","author":"Tjust","year":"2012","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.neurol.2022.11.010_bib1060","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1167\/iovs.10-7132","article-title":"Different impact of ALS on laminin isoforms in human extraocular muscles versus limb muscles","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1065","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1167\/iovs.16-20074","article-title":"Unchanged neurotrophic factors and their receptors correlate with sparing in extraocular muscles in amyotrophic lateral sclerosis","volume":"57","author":"Harandi","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1070","doi-asserted-by":"crossref","first-page":"e57473","DOI":"10.1371\/journal.pone.0057473","article-title":"Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2022.11.010_bib1075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bph.12181","article-title":"VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair","volume":"169","author":"Waschek","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/jnnp.2010.212407","article-title":"Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases","volume":"82","author":"Donaghy","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.010_bib1085","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00415-010-5478-7","article-title":"Slow saccades in bulbar-onset motor neurone disease","volume":"257","author":"Donaghy","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.10.016","article-title":"Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population","volume":"314","author":"Moss","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/21678421.2012.729217","article-title":"Blink rate in ALS","volume":"14","author":"Byrne","year":"2013","journal-title":"Amyotroph Lateral Scher Frontotemp Degenerat"},{"key":"10.1016\/j.neurol.2022.11.010_bib1095","doi-asserted-by":"crossref","first-page":"e0142546","DOI":"10.1371\/journal.pone.0142546","article-title":"Eye movement deficits are consistent with a staging model of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"10","author":"Gorges","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2022.11.010_bib1115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/21678421.2015.1054292","article-title":"Eye-tracking in amyotrophic lateral sclerosis: a longitudinal study of saccadic and cognitive tasks","volume":"17","author":"Proudfoot","year":"2016","journal-title":"Amyotroph Lateral Scher Frontotemp Degenerat"},{"key":"10.1016\/j.neurol.2022.11.010_bib1130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3988\/jcn.2018.14.4.464","article-title":"Abnormal oculomotor functions in amyotrophic lateral sclerosis","volume":"14","author":"Kang","year":"2018","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1100","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s00415-021-10510-z","article-title":"Eye movement alterations in presymptomatic C9orf72 expansion gene carriers","volume":"268","author":"Behler","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3988\/jcn.2021.17.1.96","article-title":"Ocular involvement occurs frequently at all stages of amyotrophic lateral sclerosis: preliminary experience in a large Italian cohort","volume":"17","author":"Cozza","year":"2021","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/17482968.2011.580848","article-title":"Occurrence of eye movement disorders in motor neuron disease","volume":"13","author":"Beaufils","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.neurol.2022.11.010_bib1125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/17482960902875133","article-title":"Amyotrophic lateral sclerosis and ocular flutter","volume":"11","author":"Balaratnam","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.neurol.2022.11.010_bib1135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fnagi.2014.00278","article-title":"Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis","volume":"6","author":"Ferrari","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.0b013e31821e553a","article-title":"Small-fiber neuropathy in patients with ALS","volume":"76","author":"Weis","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.010_bib1145","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P07.268","article-title":"Cross-sectional survey of visual acuity and self-reported visual function in patients with amyotrophic lateral sclerosis","volume":"78","author":"Moss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.010_bib1150","doi-asserted-by":"crossref","first-page":"e0168714","DOI":"10.1371\/journal.pone.0168714","article-title":"High and low contrast visual acuity are not affected in amyotrophic lateral sclerosis","volume":"11","author":"Moss","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2022.11.010_bib1155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/brainsci9120337","article-title":"Changes in retinal OCT and their correlations with neurological disability in early ALS patients, a follow-up study","volume":"9","author":"Rojas","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/01658107.2017.1326153","article-title":"Diffuse colour discrimination as marker of afferent visual system dysfunction in amyotrophic lateral sclerosis","volume":"41","author":"Boven","year":"2017","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.neurol.2022.11.010_bib1165","doi-asserted-by":"crossref","first-page":"e0185242","DOI":"10.1371\/journal.pone.0185242","article-title":"Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2022.11.010_bib1170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jocn.2017.10.080","article-title":"Comparison of optical coherence tomography findings and visual field changes in patients with primary open-angle glaucoma and amyotrophic lateral sclerosis","volume":"48","author":"Liu","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/21678421.2014.951941","article-title":"Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation","volume":"15","author":"Fawzi","year":"2014","journal-title":"Amyotroph Lateral Scher Frontotemp Degenerat"},{"key":"10.1016\/j.neurol.2022.11.010_bib1180","first-page":"T12","article-title":"Ophthalmic manifestations of amyotrophic lateral sclerosis (an American Ophthalmological Society Thesis)","volume":"113","author":"Volpe","year":"2015","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.neurol.2022.11.010_bib1185","unstructured":"Potenciales evocados multimodales en pacientes con esclerosis lateral amiotr\u00f3fica. https:\/\/www.medigraphic.com\/cgi-bin\/new\/resumen.cgi?IDARTICULO=477 [accessed 24 January 2022]."},{"key":"10.1016\/j.neurol.2022.11.010_bib1190","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2009.06022.x","article-title":"\u03b2-N-methylamino-l-alanine induced in vivo retinal cell death","volume":"109","author":"Santucci","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2022.11.010_bib1195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fimmu.2018.01287","article-title":"Altered functions and interactions of glaucoma-associated mutants of optineurin","volume":"9","author":"Swarup","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1200","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1111\/febs.15752","article-title":"A glaucoma- and ALS-associated mutant of OPTN induces neuronal cell death dependent on Tbk1 activity, autophagy and ER stress","volume":"288","author":"Medchalmi","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.neurol.2022.11.010_bib1205","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/ijms22041663","article-title":"Retinal ganglion cell loss and microglial activation in a SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Rojas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jnen\/nlx057","article-title":"SOD1G93A mutant mice develop a neuroinflammation-independent dendropathy in excitatory neuronal subsets of the olfactory bulb and retina","volume":"76","author":"Ringer","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1215","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1007\/s00018-019-03078-5","article-title":"Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons","volume":"76","author":"Cho","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1220","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","article-title":"p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS","volume":"122","author":"Al-Sarraj","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/acn3.46","article-title":"Subtle retinal pathology in amyotrophic lateral sclerosis","volume":"1","author":"Ringelstein","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1230","first-page":"T12","article-title":"Ophthalmic manifestations of amyotrophic lateral sclerosis (an American Ophthalmological Society Thesis)","volume":"113","author":"Volpe","year":"2015","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.neurol.2022.11.010_bib1235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00702-015-1483-4","article-title":"Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging","volume":"123","author":"H\u00fcbers","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neurol.2022.11.010_bib1240","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2016.0454","article-title":"Optical coherence tomography in patients with amyotrophic lateral sclerosis","volume":"94","author":"Rojas Lozano","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1245","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.P5.043","article-title":"Retinal degeneration detectable by optical coherence tomography as a potential biomarker for amyotrophic lateral sclerosis","volume":"86","author":"Rosen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.010_bib1250","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.3390\/brainsci9120337","article-title":"Changes in retinal OCT and their correlations with neurological disability in early ALS patients, a follow-up study","volume":"9","author":"Rojas","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurol.2022.11.010_bib1255","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-018-8863-2","article-title":"Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression","volume":"265","author":"Rohani","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00415-018-8787-x","article-title":"In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis","volume":"265","author":"Abdelhak","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/EB.S193026","article-title":"Optical coherence tomography angiography in neurodegenerative diseases: a review","volume":"12","author":"Tsokolas","year":"2020","journal-title":"Eye Brain"},{"key":"10.1016\/j.neurol.2022.11.010_bib1270","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/ene.12146","article-title":"Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis","volume":"20","author":"Roth","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.11.010_bib1275","doi-asserted-by":"crossref","first-page":"29187","DOI":"10.1038\/srep29187","article-title":"Macular sub-layer thinning and association with pulmonary function tests in amyotrophic lateral sclerosis","volume":"6","author":"Simonett","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2022.11.010_bib1280","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-018-8863-2","article-title":"Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression","volume":"265","author":"Rohani","year":"2018","journal-title":"J Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723008184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:47:05Z","timestamp":1758520025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723008184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0035378723008184"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.11.010","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal vessels as a window on amyotrophic lateral sclerosis pathophysiology: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}